Suchergebnisse - "antitumor immune response"

PubPharm (10)

1

Association between durable response (DR) and overall survival (OS) in patients with unresected stage IIIb-IV melanoma treated with Talimogene Laherparepvec (T-VEC) in the Phase III OPTiM trial

enthalten in: Journal for ImmunoTherapy of Cancer | 2014

von Kaufman, H. | Andtbacka, R. | Collichio, F. | +5

2

Final planned overall survival (OS) from OPTiM, a randomized Phase III trial of talimogene laherparepvec (T-VEC) versus GM-CSF for the treatment of unresected stage IIIB/C/IV melanoma (NCT00769704)

enthalten in: Journal for ImmunoTherapy of Cancer | 2014

von Andtbacka, R. | Collichio, F. | Amatruda, T. | +13

3

Association between durable response (DR) and overall survival (OS) in patients with unresected stage IIIb-IV melanoma treated with Talimogene Laherparepvec (T-VEC) in the Phase III OPTiM trial

enthalten in: Journal for ImmunoTherapy of Cancer | 2014

von Kaufman, H. | Andtbacka, R. | Collichio, F. | +5

4

Final planned overall survival (OS) from OPTiM, a randomized Phase III trial of talimogene laherparepvec (T-VEC) versus GM-CSF for the treatment of unresected stage IIIB/C/IV melanoma (NCT00769704)

enthalten in: Journal for ImmunoTherapy of Cancer | 2014

von Andtbacka, R. | Collichio, F. | Amatruda, T. | +13

5

Immunological Impact of Neoadjuvant Chemoradiotherapy in Patients with Borderline Resectable Pancreatic Ductal Adenocarcinoma

enthalten in: Annals of surgical oncology | 2013

von Homma, Y. | Taniguchi, K. | Murakami, T. | +9

6

Immunological Impact of Neoadjuvant Chemoradiotherapy in Patients with Borderline Resectable Pancreatic Ductal Adenocarcinoma

enthalten in: Annals of surgical oncology | 2013

von Homma, Y. | Taniguchi, K. | Murakami, T. | +9

7

Immunological Impact of Neoadjuvant Chemoradiotherapy in Patients with Borderline Resectable Pancreatic Ductal Adenocarcinoma

enthalten in: Annals of surgical oncology | 2013

von Homma, Y. | Taniguchi, K. | Murakami, T. | +9

8

Advances in immunotherapy for colorectal malignancies

enthalten in: Current colorectal cancer reports | 2008

von McKinney, M. | Morse, M.

9

Advances in immunotherapy for colorectal malignancies

enthalten in: Current colorectal cancer reports | 2008

von McKinney, M. | Morse, M.

10

Advances in immunotherapy for colorectal malignancies

enthalten in: Current colorectal cancer reports | 2008

von McKinney, M. | Morse, M.

1
[1]